Arcutis Biotherapeutics

Drug development dermatology


HBM contact: Dr Ivo Staijen, Dr Alexander Asam

Company status: public

Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171